| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.91B | 117.09B | 125.54B | 145.90B | 135.45B | 125.51B |
| Gross Profit | 20.62B | 20.92B | 21.91B | 27.73B | 23.20B | 24.77B |
| EBITDA | 12.73B | 11.70B | 13.06B | 15.75B | 10.26B | 14.50B |
| Net Income | 5.69B | 6.20B | 4.47B | 7.84B | 4.42B | 3.98B |
Balance Sheet | ||||||
| Total Assets | 121.14B | 129.64B | 132.65B | 129.42B | 125.92B | 112.52B |
| Cash, Cash Equivalents and Short-Term Investments | 11.99B | 12.43B | 12.64B | 8.94B | 8.63B | 5.72B |
| Total Debt | 5.35B | 5.54B | 4.38B | 5.97B | 7.78B | 9.95B |
| Total Liabilities | 49.47B | 49.52B | 61.70B | 64.68B | 70.90B | 63.12B |
| Stockholders Equity | 70.84B | 79.11B | 70.05B | 64.04B | 54.33B | 48.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.43B | 7.40B | 8.05B | 7.64B | 3.11B |
| Operating Cash Flow | 0.00 | 12.01B | 11.05B | 13.37B | 13.01B | 9.21B |
| Investing Cash Flow | 0.00 | -10.76B | -4.73B | -9.61B | -5.91B | -6.68B |
| Financing Cash Flow | 0.00 | -2.12B | -3.04B | -3.80B | -4.40B | -2.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥49.76B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
78 Outperform | ¥296.83B | 8.56 | 6.37% | 2.88% | 4.86% | 10.95% | |
76 Outperform | ¥726.94B | 14.05 | 7.20% | 2.41% | -0.73% | 88.36% | |
75 Outperform | ¥504.17B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
72 Outperform | ¥8.04T | 15.56 | 8.97% | 1.38% | 4.96% | 8.64% | |
67 Neutral | ¥5.40T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |